Statistics for Amicus Therapeutics (id:6415 FOLD)

Valuation metrics

Market cap

2.89B

Enterprise value

3.09B

Trailing P/E (ttm)

-18.94

Forward P/E

60.38

PEG ratio

60.38

Price/Sales (ttm)

5.85

Price/Book (mrq)

16.13

Enterprise Value/Revenue

6.25

Enterprise Value/EBITDA

133.72

Overview

Shares outstanding

298.81M

Float

241.08M

Shares short

19.90M

% Held by insiders

0.01%

% Held by institutions

1.05%

Average volume (10 days)

2.98M

Average volume (90 days)

Price summary

52-Week low

9.02

52-Week high

14.57

52-Week change

-9.63%

Beta

0.67

50-Day moving average

11.00

200-Day moving average

11.05

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-21.21%

Operating margin

17.53%

Operational effectiveness

Return on assets

1.16%

Return on equity

-67.09%

Income statement

Revenue (ttm)

1.63

Revenue per share (ttm)

1.63

Quarterly revenue growth (yoy)

Gross profit (ttm)

362.03M

EBITDA

23.09M

Net income to common (ttm)

-104,688,000.00

Diluted EPS (ttm)

-0.34

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

249.76M

Total cash per share (mrq)

0.84

Total debt (mrq)

444.66M

Total Debt/Equity (mrq)

248.66

Current ratio (mrq)

315.20%

Book value per share (mrq)

0.60

Cash flow

Cash flow statement

-26,517,000.00

Levered free cash flow (LFCF)

-10,718,250.00